Attached files
| file | filename |
|---|---|
| 10-Q/A - PROTECT PHARMACEUTICAL Corp | v197218_10qa.htm |
| EX-31.1 - PROTECT PHARMACEUTICAL Corp | v197218_ex31-1.htm |
Exhibit
32.1
CERTIFICATION
PURSUANT TO
18
U.S.C. SECTION 1350,
AS
ADOPTED PURSUANT TO
SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report
of Protect Pharmaceutical Corporation (the “Company”) on Form 10-Q for the
period ended June 30, 2010, as filed with the Securities and Exchange Commission
on the date hereof (the “Report”), I, William D. Abajian, Chief
Executive Officer and Principal Accounting Officer of the Company, certify,
pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of the
Sarbanes-Oxley Act of 2002, that:
(1)
The Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and
(2)
The information contained in the Report fairly presents, in all material
respects, the financial condition and result of operations of the
Company.
|
/s/
William
D. Abajian
|
|
|
William
D. Abajian
|
|
|
Chief
Executive Officer
|
|
|
Acting
Principal Accounting Officer
|
|
|
September
22, 2010
|
A signed
original of this written statement required by Section 906, or other document
authenticating, acknowledging, or otherwise adopting the signature that appears
in typed form within the electronic version of this written statement has been
provided to the Company and will be retained by the Company and furnished to the
Securities and Exchange Commission or its staff upon request. The
foregoing certifications are accompanying the Company's Form 10-Q solely
pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and
(b) of section 1350, chapter 63 of title 18, United States Code) and is not
being filed as part of the Form 10-Q or as a separate disclosure
document.